UniProt ID | TFR1_HUMAN | |
---|---|---|
UniProt AC | P02786 | |
Protein Name | Transferrin receptor protein 1 | |
Gene Name | TFRC | |
Organism | Homo sapiens (Human). | |
Sequence Length | 760 | |
Subcellular Localization |
Cell membrane Single-pass type II membrane protein . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Transferrin receptor protein 1, serum form: Secreted . |
|
Protein Description | Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake. [PubMed: 26642240; (Microbial infection) Acts as a receptor for new-world arenaviruses: Guanarito, Junin and Machupo virus.] | |
Protein Sequence | MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDEEENADNNTKANVTKPKRCSGSICYGTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLAGTESPVREEPGEDFPAARRLYWDDLKRKLSEKLDSTDFTGTIKLLNENSYVPREAGSQKDENLALYVENQFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQRDAWGPGAAKSGVGTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDFGNAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNGAFNETLFRNQLALATWTIQGAANALSGDVWDIDNEF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MMDQARSAFSNLFG -CHHHHHHHHHHHHC | 36.36 | 21945579 | |
10 | Phosphorylation | DQARSAFSNLFGGEP HHHHHHHHHHHCCCC | 32.13 | 21945579 | |
19 | Phosphorylation | LFGGEPLSYTRFSLA HHCCCCCCEEEEEEE | 34.86 | 21945579 | |
20 | Phosphorylation | FGGEPLSYTRFSLAR HCCCCCCEEEEEEEE | 15.04 | 25159151 | |
21 | Phosphorylation | GGEPLSYTRFSLARQ CCCCCCEEEEEEEEE | 23.12 | 21945579 | |
24 | Phosphorylation | PLSYTRFSLARQVDG CCCEEEEEEEEECCC | 20.16 | 10531064 | |
34 | Phosphorylation | RQVDGDNSHVEMKLA EECCCCCCCEEEEEE | 33.38 | 23401153 | |
39 | Ubiquitination | DNSHVEMKLAVDEEE CCCCEEEEEEECCHH | 21.57 | 21906983 | |
52 | Phosphorylation | EENADNNTKANVTKP HHCCCCCCCCCCCCC | 37.48 | 25159151 | |
53 | Acetylation | ENADNNTKANVTKPK HCCCCCCCCCCCCCC | 39.84 | 7960211 | |
53 | Ubiquitination | ENADNNTKANVTKPK HCCCCCCCCCCCCCC | 39.84 | 21906983 | |
53 | 2-Hydroxyisobutyrylation | ENADNNTKANVTKPK HCCCCCCCCCCCCCC | 39.84 | - | |
58 | Ubiquitination | NTKANVTKPKRCSGS CCCCCCCCCCCCCCC | 44.23 | 21906983 | |
60 | Ubiquitination | KANVTKPKRCSGSIC CCCCCCCCCCCCCHH | 68.54 | - | |
62 | S-palmitoylation | NVTKPKRCSGSICYG CCCCCCCCCCCHHHH | 7.25 | 3582362 | |
67 | S-palmitoylation | KRCSGSICYGTIAVI CCCCCCHHHHHHHHH | 2.48 | 2398066 | |
95 | Acetylation | YCKGVEPKTECERLA HHCCCCCCHHHHHHC | 43.37 | 26051181 | |
104 | O-linked_Glycosylation | ECERLAGTESPVREE HHHHHCCCCCCCCCC | 27.90 | 1421756 | |
104 | Phosphorylation | ECERLAGTESPVREE HHHHHCCCCCCCCCC | 27.90 | 26434776 | |
104 | O-linked_Glycosylation | ECERLAGTESPVREE HHHHHCCCCCCCCCC | 27.90 | 1421756 | |
106 | Phosphorylation | ERLAGTESPVREEPG HHHCCCCCCCCCCCC | 28.65 | 25159151 | |
106 | O-linked_Glycosylation | ERLAGTESPVREEPG HHHCCCCCCCCCCCC | 28.65 | OGP | |
123 | Phosphorylation | FPAARRLYWDDLKRK CHHHHHHCHHHHHHH | 12.65 | 20068231 | |
128 | Acetylation | RLYWDDLKRKLSEKL HHCHHHHHHHHHHHC | 55.25 | 27452117 | |
128 | Ubiquitination | RLYWDDLKRKLSEKL HHCHHHHHHHHHHHC | 55.25 | - | |
128 | 2-Hydroxyisobutyrylation | RLYWDDLKRKLSEKL HHCHHHHHHHHHHHC | 55.25 | - | |
128 | Succinylation | RLYWDDLKRKLSEKL HHCHHHHHHHHHHHC | 55.25 | 23954790 | |
130 | Ubiquitination | YWDDLKRKLSEKLDS CHHHHHHHHHHHCCC | 55.57 | - | |
132 | Phosphorylation | DDLKRKLSEKLDSTD HHHHHHHHHHCCCCC | 35.40 | 29457462 | |
134 | Ubiquitination | LKRKLSEKLDSTDFT HHHHHHHHCCCCCCC | 54.97 | - | |
134 | 2-Hydroxyisobutyrylation | LKRKLSEKLDSTDFT HHHHHHHHCCCCCCC | 54.97 | - | |
143 | O-linked_Glycosylation | DSTDFTGTIKLLNEN CCCCCCCCEEECCCC | 16.33 | OGP | |
145 | Ubiquitination | TDFTGTIKLLNENSY CCCCCCEEECCCCCC | 46.92 | 21906983 | |
145 | 2-Hydroxyisobutyrylation | TDFTGTIKLLNENSY CCCCCCEEECCCCCC | 46.92 | - | |
161 | Ubiquitination | PREAGSQKDENLALY CCCCCCCCCCCHHHH | 69.57 | 21906983 | |
161 | 2-Hydroxyisobutyrylation | PREAGSQKDENLALY CCCCCCCCCCCHHHH | 69.57 | - | |
168 | Phosphorylation | KDENLALYVENQFRE CCCCHHHHHHHHHHH | 10.50 | - | |
177 | Ubiquitination | ENQFREFKLSKVWRD HHHHHHHHCHHHHCC | 47.28 | - | |
189 | Ubiquitination | WRDQHFVKIQVKDSA HCCCCEEEEEECCCC | 26.86 | - | |
189 | 2-Hydroxyisobutyrylation | WRDQHFVKIQVKDSA HCCCCEEEEEECCCC | 26.86 | - | |
189 | Acetylation | WRDQHFVKIQVKDSA HCCCCEEEEEECCCC | 26.86 | 27452117 | |
193 | Ubiquitination | HFVKIQVKDSAQNSV CEEEEEECCCCCCEE | 29.59 | - | |
195 | Phosphorylation | VKIQVKDSAQNSVII EEEEECCCCCCEEEE | 26.49 | 21712546 | |
199 | Phosphorylation | VKDSAQNSVIIVDKN ECCCCCCEEEEEECC | 11.56 | 21712546 | |
205 | Ubiquitination | NSVIIVDKNGRLVYL CEEEEEECCCCEEEE | 50.86 | 21906983 | |
205 | 2-Hydroxyisobutyrylation | NSVIIVDKNGRLVYL CEEEEEECCCCEEEE | 50.86 | - | |
211 | Phosphorylation | DKNGRLVYLVENPGG ECCCCEEEEEECCCC | 15.04 | 28152594 | |
219 | Phosphorylation | LVENPGGYVAYSKAA EEECCCCEEEECEEE | 6.45 | 28152594 | |
222 | Phosphorylation | NPGGYVAYSKAATVT CCCCEEEECEEEEEE | 10.72 | 28152594 | |
223 | Phosphorylation | PGGYVAYSKAATVTG CCCEEEECEEEEEEE | 13.19 | 28152594 | |
224 | Ubiquitination | GGYVAYSKAATVTGK CCEEEECEEEEEEEC | 29.39 | 21906983 | |
231 | Ubiquitination | KAATVTGKLVHANFG EEEEEEECEEECCCC | 37.66 | - | |
240 | Ubiquitination | VHANFGTKKDFEDLY EECCCCCCCCHHHHC | 51.21 | - | |
240 | 2-Hydroxyisobutyrylation | VHANFGTKKDFEDLY EECCCCCCCCHHHHC | 51.21 | - | |
241 | Ubiquitination | HANFGTKKDFEDLYT ECCCCCCCCHHHHCC | 68.44 | - | |
248 | Phosphorylation | KDFEDLYTPVNGSIV CCHHHHCCCCCCEEE | 28.23 | 21601212 | |
251 | N-linked_Glycosylation | EDLYTPVNGSIVIVR HHHCCCCCCEEEEEE | 39.43 | 10531064 | |
251 | N-linked_Glycosylation | EDLYTPVNGSIVIVR HHHCCCCCCEEEEEE | 39.43 | 10531064 | |
261 | Ubiquitination | IVIVRAGKITFAEKV EEEEECCEEEHHHHH | 37.27 | - | |
261 | 2-Hydroxyisobutyrylation | IVIVRAGKITFAEKV EEEEECCEEEHHHHH | 37.27 | - | |
282 | Phosphorylation | NAIGVLIYMDQTKFP CEEEEEEEECCCCCC | 7.17 | - | |
286 | Phosphorylation | VLIYMDQTKFPIVNA EEEEECCCCCCEECE | 30.32 | - | |
317 | N-linked_Glycosylation | TPGFPSFNHTQFPPS CCCCCCCCCCCCCCC | 41.45 | 10531064 | |
317 | N-linked_Glycosylation | TPGFPSFNHTQFPPS CCCCCCCCCCCCCCC | 41.45 | 10531064 | |
326 | Phosphorylation | TQFPPSRSSGLPNIP CCCCCCCCCCCCCCC | 32.85 | 23911959 | |
327 | Phosphorylation | QFPPSRSSGLPNIPV CCCCCCCCCCCCCCH | 43.15 | 23911959 | |
338 | Phosphorylation | NIPVQTISRAAAEKL CCCHHHHCHHHHHHH | 21.18 | 21712546 | |
344 | Ubiquitination | ISRAAAEKLFGNMEG HCHHHHHHHHCCCCC | 44.37 | - | |
344 | 2-Hydroxyisobutyrylation | ISRAAAEKLFGNMEG HCHHHHHHHHCCCCC | 44.37 | - | |
353 | Glutathionylation | FGNMEGDCPSDWKTD HCCCCCCCCCCCCCC | 5.23 | 22555962 | |
358 | Ubiquitination | GDCPSDWKTDSTCRM CCCCCCCCCCCCEEE | 47.66 | - | |
371 | Ubiquitination | RMVTSESKNVKLTVS EEECCCCCCCEEEHH | 62.80 | - | |
374 | Ubiquitination | TSESKNVKLTVSNVL CCCCCCCEEEHHHHH | 48.08 | - | |
376 | Phosphorylation | ESKNVKLTVSNVLKE CCCCCEEEHHHHHHH | 19.03 | 21955146 | |
378 | Phosphorylation | KNVKLTVSNVLKEIK CCCEEEHHHHHHHHH | 18.91 | 21955146 | |
382 | Ubiquitination | LTVSNVLKEIKILNI EEHHHHHHHHHHHCH | 53.78 | 21906983 | |
382 | Acetylation | LTVSNVLKEIKILNI EEHHHHHHHHHHHCH | 53.78 | 27452117 | |
385 | Ubiquitination | SNVLKEIKILNIFGV HHHHHHHHHHCHHEH | 42.08 | - | |
394 | Acetylation | LNIFGVIKGFVEPDH HCHHEHHCCCCCCCE | 43.84 | 20167786 | |
394 | Ubiquitination | LNIFGVIKGFVEPDH HCHHEHHCCCCCCCE | 43.84 | - | |
402 | Phosphorylation | GFVEPDHYVVVGAQR CCCCCCEEEEEEEEC | 11.43 | 28152594 | |
418 | Acetylation | AWGPGAAKSGVGTAL CCCCCHHHCCHHHHH | 47.40 | 20167786 | |
418 | Ubiquitination | AWGPGAAKSGVGTAL CCCCCHHHCCHHHHH | 47.40 | 21906983 | |
418 | 2-Hydroxyisobutyrylation | AWGPGAAKSGVGTAL CCCCCHHHCCHHHHH | 47.40 | - | |
419 | Phosphorylation | WGPGAAKSGVGTALL CCCCHHHCCHHHHHH | 33.70 | 21712546 | |
432 | Sulfoxidation | LLLKLAQMFSDMVLK HHHHHHHHHHHHHHC | 2.63 | 21406390 | |
439 | 2-Hydroxyisobutyrylation | MFSDMVLKDGFQPSR HHHHHHHCCCCCCCC | 44.38 | - | |
480 | Phosphorylation | SLHLKAFTYINLDKA HCHHHEEEEEECCCH | 28.49 | 23286773 | |
481 | Phosphorylation | LHLKAFTYINLDKAV CHHHEEEEEECCCHH | 4.95 | 23286773 | |
486 | Ubiquitination | FTYINLDKAVLGTSN EEEEECCCHHHCCCC | 43.49 | - | |
486 | 2-Hydroxyisobutyrylation | FTYINLDKAVLGTSN EEEEECCCHHHCCCC | 43.49 | - | |
491 | Phosphorylation | LDKAVLGTSNFKVSA CCCHHHCCCCCEECC | 19.14 | 23286773 | |
492 | Phosphorylation | DKAVLGTSNFKVSAS CCHHHCCCCCEECCC | 38.17 | 23286773 | |
495 | 2-Hydroxyisobutyrylation | VLGTSNFKVSASPLL HHCCCCCEECCCHHH | 39.26 | - | |
497 | Phosphorylation | GTSNFKVSASPLLYT CCCCCEECCCHHHHH | 24.50 | 23286773 | |
499 | Phosphorylation | SNFKVSASPLLYTLI CCCEECCCHHHHHHH | 14.47 | 20068231 | |
503 | Phosphorylation | VSASPLLYTLIEKTM ECCCHHHHHHHHHHH | 13.74 | 20068231 | |
504 | Phosphorylation | SASPLLYTLIEKTMQ CCCHHHHHHHHHHHH | 22.64 | 28060719 | |
508 | Ubiquitination | LLYTLIEKTMQNVKH HHHHHHHHHHHCCCC | 42.16 | - | |
509 | Phosphorylation | LYTLIEKTMQNVKHP HHHHHHHHHHCCCCC | 15.93 | 21601212 | |
514 | Ubiquitination | EKTMQNVKHPVTGQF HHHHHCCCCCCCCCE | 50.14 | - | |
514 | 2-Hydroxyisobutyrylation | EKTMQNVKHPVTGQF HHHHHCCCCCCCCCE | 50.14 | - | |
514 | Acetylation | EKTMQNVKHPVTGQF HHHHHCCCCCCCCCE | 50.14 | 21466224 | |
518 | O-linked_Glycosylation | QNVKHPVTGQFLYQD HCCCCCCCCCEEECC | 29.71 | OGP | |
523 | Phosphorylation | PVTGQFLYQDSNWAS CCCCCEEECCCCHHH | 16.15 | 28152594 | |
531 | Ubiquitination | QDSNWASKVEKLTLD CCCCHHHHEEEEECC | 46.82 | 21906983 | |
531 | Acetylation | QDSNWASKVEKLTLD CCCCHHHHEEEEECC | 46.82 | 27452117 | |
534 | Ubiquitination | NWASKVEKLTLDNAA CHHHHEEEEECCCCH | 50.16 | - | |
572 | Phosphorylation | YLGTTMDTYKELIER CCCCCHHHHHHHHHH | 26.18 | - | |
573 | Phosphorylation | LGTTMDTYKELIERI CCCCHHHHHHHHHHH | 9.75 | - | |
585 | Ubiquitination | ERIPELNKVARAAAE HHHHHHHHHHHHHHH | 50.31 | - | |
585 | 2-Hydroxyisobutyrylation | ERIPELNKVARAAAE HHHHHHHHHHHHHHH | 50.31 | - | |
611 | Phosphorylation | DVELNLDYERYNSQL CEEECCCHHHHHHHH | 12.89 | - | |
614 | Phosphorylation | LNLDYERYNSQLLSF ECCCHHHHHHHHHHH | 13.76 | 28152594 | |
616 | Phosphorylation | LDYERYNSQLLSFVR CCHHHHHHHHHHHHH | 17.17 | 21712546 | |
620 | Phosphorylation | RYNSQLLSFVRDLNQ HHHHHHHHHHHHHHH | 30.23 | 21712546 | |
654 | Phosphorylation | GDFFRATSRLTTDFG CCHHHHCCCEECCCC | 25.06 | 21601212 | |
658 | Phosphorylation | RATSRLTTDFGNAEK HHCCCEECCCCCCHH | 33.64 | 17081983 | |
665 | Ubiquitination | TDFGNAEKTDRFVMK CCCCCCHHHCHHHHH | 54.00 | 21906983 | |
665 | 2-Hydroxyisobutyrylation | TDFGNAEKTDRFVMK CCCCCCHHHCHHHHH | 54.00 | - | |
666 | Phosphorylation | DFGNAEKTDRFVMKK CCCCCHHHCHHHHHH | 24.74 | 21601212 | |
683 | Phosphorylation | DRVMRVEYHFLSPYV HCEEEEEEEECCCCC | 8.60 | 28152594 | |
687 | Phosphorylation | RVEYHFLSPYVSPKE EEEEEECCCCCCCCC | 17.16 | 28152594 | |
689 | Phosphorylation | EYHFLSPYVSPKESP EEEECCCCCCCCCCC | 15.35 | 28152594 | |
691 | Phosphorylation | HFLSPYVSPKESPFR EECCCCCCCCCCCCC | 25.14 | 26437602 | |
693 | Ubiquitination | LSPYVSPKESPFRHV CCCCCCCCCCCCCCC | 64.42 | 2190698 | |
693 | 2-Hydroxyisobutyrylation | LSPYVSPKESPFRHV CCCCCCCCCCCCCCC | 64.42 | - | |
717 | Ubiquitination | PALLENLKLRKQNNG HHHHHHHHHHHHCCC | 58.80 | - | |
720 | Ubiquitination | LENLKLRKQNNGAFN HHHHHHHHHCCCCCC | 68.74 | - | |
722 | N-linked_Glycosylation | NLKLRKQNNGAFNET HHHHHHHCCCCCCHH | 52.52 | 19349973 | |
722 | N-linked_Glycosylation | NLKLRKQNNGAFNET HHHHHHHCCCCCCHH | 52.52 | 19349973 | |
727 | N-linked_Glycosylation | KQNNGAFNETLFRNQ HHCCCCCCHHHHHCH | 40.59 | 10531064 | |
727 | N-linked_Glycosylation | KQNNGAFNETLFRNQ HHCCCCCCHHHHHCH | 40.59 | 7780197 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
20 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
24 | S | Phosphorylation | Kinase | KPCA | P17252 | PhosphoELM |
24 | S | Phosphorylation | Kinase | PRKCA | P20444 | GPS |
24 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
24 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO6 | Q9NRD1 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF2 | Q9P0N8 | PMID:14722266 |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF1 | Q8TCQ1 | PMID:14722266 |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF8 | Q5T0T0 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TFR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HFE_HUMAN | HFE | physical | 9465039 | |
GBRAP_HUMAN | GABARAP | physical | 11997026 | |
AP2M_ARATH | AT5G46630 | physical | 17059402 | |
TFR1_HUMAN | TFRC | physical | 10531064 | |
TRFE_HUMAN | TF | physical | 11027676 | |
HFE_HUMAN | HFE | physical | 11027676 | |
OPTN_HUMAN | OPTN | physical | 20085643 | |
HGS_HUMAN | HGS | physical | 11988743 | |
SH3B4_HUMAN | SH3BP4 | physical | 16325581 | |
B4GT1_HUMAN | B4GALT1 | physical | 7744867 | |
RANB9_HUMAN | RANBP9 | physical | 14722085 | |
RAB8A_HUMAN | RAB8A | physical | 22854040 | |
ARFG1_HUMAN | ARFGAP1 | physical | 21499258 | |
AP2B1_HUMAN | AP2B1 | physical | 21499258 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251, AND MASSSPECTROMETRY. | |
O-linked Glycosylation | |
Reference | PubMed |
"Identification of the O-linked glycosylation site of the humantransferrin receptor."; Hayes G.R., Enns C.A., Lucas J.J.; Glycobiology 2:355-359(1992). Cited for: GLYCOSYLATION AT THR-104. | |
"Presence of O-linked oligosaccharide on a threonine residue in thehuman transferrin receptor."; Do S.-I., Cummings R.D.; Glycobiology 2:345-353(1992). Cited for: GLYCOSYLATION AT THR-104. | |
Palmitoylation | |
Reference | PubMed |
"Identification of the intermolecular disulfide bonds of the humantransferrin receptor and its lipid-attachment site."; Jing S., Trowbridge I.S.; EMBO J. 6:327-331(1987). Cited for: PALMITOYLATION AT CYS-62. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. |